Trial intelligence / Profile preview

Magnesium Infusion for Emergence Agitation in Lumbar Microdiscectomy

NCT07139847Not yet recruiting

Sponsor
Ondokuz Mayıs University
Start
Dec 2025
Primary completion
Jul 2026
Modality
Small Molecules
01

Overview

Randomised, double-blind trial of magnesium sulfate in Emergence agitation (EA) (2 arms), sponsored by Ondokuz Mayıs University. Primary endpoint: Incidence of Emergence Agitation in the PACU at 30 months. Planned start Dec 2025; status: not yet recruiting.

02

Drugs

magnesium sulfate
03

Conditions

Emergence agitation (EA)

Beyond the preview

Go deeper on NCT07139847.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07139847.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call